Global Artificial Tears Market: Market Driver and Restraint
Applications of Artificial Tears are anticipated to create new business segments in the market. Artificial Tears is in use for a broad range of Conjunctival epithelial dryness products such as Office worker, Student & others. The companies are focusing on launching products that are launched in few regions. There lies a great opportunity since only a few companies are into this business due to introductory stage of this product market. Artificial Tears application is developed towards a more active mode.
Manufacturers are exploring the potential of Artificial Tears in Substantial conjunctival corneal dryness. Products of Artificial Tears in Vacuum packaging are gaining traction in the recent years. Recently, consumers have gradually gaining focus of Artificial Tears in the Dry eye syndrome area. Further, there are also potential uses in developing regions.
Global Artificial Tears Market: Key Takeaways
· On the one hand, Artificial Tears manufacturers are dedicated to lowering their manufacturing cost; on the other hand, they try to provide more qualified products to customers.
· Besides, they are trying to broaden the applications of Artificial Tears such as Dry eye syndrome.
· Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service.
Global Artificial Tears Market: Forecast by Form
This segment includes Artificial Tear Liquid, Artificial Tear Ointment, etc. In terms of volume, Artificial Tear Liquid segment is expected to remain dominant in the global Artificial Tears market.
Global Artificial Tears Market: Forecast by Region
North America, Latin America, Eastern Europe, Western Europe, APEJ, Japan and MEA are the seven regions that are included in this report. USA is the dominant market in the global 1, 2-Propanediol market in terms of value. The USA1, 2-Propanediol market was estimated to be valued at US$ 1032.41 Mn in 2017 and is expected to expand at a value CAGR of 11.3% over the forecast period. The Europe market is expected to expand at a robust rate of 11.1% in terms of revenue over the forecast period due to the steadily increasing production capacity for Office worker products in this region.
Global Artificial Tears Market: Key Players
Allergan, Alcon (Novartis), Bausch & Lomb, Abbott, Santen Pharmaceutical, Ursapharm, Rohto, Similasan Corporation, Johnson & Johnson, Ocusoft, Nicox, Sintong, Wuhan Yuanda, Jiangxi Zhenshiming, etc. are the key vendors included in this report.
The market of Artificial Tears is very fragmented. Of the 2017 global market, the top 10 companies, all multinational, account for less than 0.4 of sales. Allergan Chemical is by far the leader, followed by Alcon (Novartis) and Bausch & Lomb. A number of producers are in China, many small and domestic. However, there are also multinational producers that supply high-quality product to the export-oriented market.
Click to view the full report TOC, figure and tables：